Revenue: $750,604,000 in Q3 2024; QoQ increase of 50.00% (from prior quarter data); YoY not disclosed (N/A).
Operating Income: -$1,156,567,000; QoQ improvement of 22.59% (negative to less negative), YoY change is not directly comparable due to SPAC structure.
Net Income: -$3,428,696,000; QoQ change -175.43%; YoY change -264,252.23% (both indicate continued accrual-driven losses typical of a shell/SPAC in transition).
EBITDA: -$1,156,567,000; EBITDARatio: -1.54.
Earnings Per Share (EPS): -$181.14; Diluted EPS: -$162.12; Weighted Avg Shares Out: 18.929 million; Diluted: 21.149 million.
Assets: Total assets $198,685,546,000; Cash and Cash Equivalents $175,592,267,000; Total Current Assets $175,620,559,000; Total Liabilities $211,216,203,000; Total Stockholdersโ Equity -$12,530,657,000; Net Debt: -$175,592,267,000 (net cash).
Liquidity: Current ratio 35.85; Quick ratio 35.85; Cash ratio 35.84.
Valuation & Multiples: Price/Book = -0.00986; Price/Earnings = -0.00901; Enterprise Value Multiple = 151.72; Price to Sales = 0.165; Dividend Yield = 0%.
Cash Flow: Operating cash flow per share 0; Free cash flow per share 0; CFO/Sales 0; Net cash position dominates the balance sheet rather than cash flow from operations.
Other: Preferred stock $199,999,950,000; Common stock $198,687,439,000; Retained earnings negative $12.53 billion.